sodium chloride
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | THAM | — | 1965-12-16 | fda.gov ↗ |
Trials 100 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 05 trials | ||||||
| Phase 0 | NCT05634213 | Mar 2023 → Apr 2025 | cardiac valvular defect | Ottawa Heart Institute Research Corporation | Withdrawn | No outcome recorded |
| Phase 0 | NCT06139029 | Nov 2022 → Mar 2023 | acute bronchiolitis | Mardan Medical Complex | Completed | No outcome recorded |
| Phase 0 | NCT05029596 | Feb 2020 → Mar 2023 | cancer | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 0 | NCT03837470 | May 2019 → Feb 2020 | diastolic heart failure | Adhish Agarwal | Completed | No outcome recorded |
| Phase 0 | NCT04197245 | Jan → Jul 2019 | skin atrophy | Jinnah Postgraduate Medical Centre | Completed | No outcome recorded |
| Phase 15 trials | ||||||
| Phase 1 | NCT05154968 | Nov → Dec 2021 | — | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 1 | NCT04147182 | Dec 2018 → Jul 2019 | — | Dan Leibovici | Unknown | No outcome recorded |
| Phase 1 | NCT02947126 | Jan 2017 → Feb 2020 | cystic fibrosis | Tim Corcoran | Completed | No outcome recorded |
| Phase 1 | NCT02854683 | Feb 2016 → Dec 2021 | myalgic encephalomeyelitis/chronic fatigue syndrome, neurally mediated hypotension, postural orthostatic tachycardia syndrome | New York Medical College | Unknown | No outcome recorded |
| Phase 1 | NCT01094704 | Nov 2009 → May 2010 | cystic fibrosis | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT06820164 | May 2025 → Jan 2027 expected | lipoma | West Virginia University | Recruiting | No outcome recorded |
| Phase 1/2 | NCT06370975 | Aug 2024 → Aug 2025 | — | Assiut University | Unknown | No outcome recorded |
| Phase 1/2 | NCT01073787 | Jul 2010 → Nov 2012 | migraine disorder | University of Alberta | Completed | No outcome recorded |
| Phase 1/2 | NCT00228657 | Jul 2002 → Aug 2003 | decubitus ulcer | Bayside Health | Completed | No outcome recorded |
| Phase 28 trials | ||||||
| Phase 2 | NCT06471998 | Feb 2025 → Mar 2026 | chronic pain syndrome | Ramsay Santé | Completed | No outcome recorded |
| Phase 2 | NCT04344236 | Apr → May 2020 | COVID-19 | NYU Langone Health | Withdrawn | No outcome recorded |
| Phase 2 | NCT04785755 | Nov 2017 → Mar 2020 | — | Hala Abd EL-Tawab Ibrahim Radwan | Completed | No outcome recorded |
| Phase 2 | NCT01042015 | Oct 2016 → Nov 2025 | cardiac arrest | University of Maryland, Baltimore | Terminated | No outcome recorded |
| Phase 2 | NCT02142985 | Apr 2014 → Apr 2015 | — | University of Monastir | Completed | No outcome recorded |
| Phase 2 | NCT01411852 | Mar 2012 → Apr 2013 | brain injury | University of Washington | Completed | No outcome recorded |
| Phase 2 | NCT00819416 | Feb → Oct 2009 | infectious disease with sepsis | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT01293084 | Jul 2007 → Jun 2009 | cystic fibrosis | Johns Hopkins University | Completed | No outcome recorded |
| Phase 2/36 trials | ||||||
| Phase 2/3 | NCT06558461 | Jun 2022 → May 2024 | acute bronchiolitis | Can Tho University of Medicine and Pharmacy | Completed | No outcome recorded |
| Phase 2/3 | NCT04802408 | Oct 2021 → May 2026 overdue | COVID-19 | Milton S. Hershey Medical Center | Active not recruiting | No outcome recorded |
| Phase 2/3 | NCT04802785 | Jun → Jul 2021 | — | Dinara Zhumanbayeva | Unknown | No outcome recorded |
| Phase 2/3 | NCT04242368 | Jul 2020 → Jul 2021 | chronic rhinosinusitis | Stanford University | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT00619918 | Feb 2008 → May 2011 | bronchiolitis | Children's Hospital Los Angeles | Completed | No outcome recorded |
| Phase 2/3 | NCT00163852 | Feb 2004 → Feb 2006 | cystic fibrosis | Bayside Health | Unknown | No outcome recorded |
| Phase 313 trials | ||||||
| Phase 3 | NCT07596329 | Sep 2026 → Nov 2027 expected | chronic kidney disease, congestive heart failure | University of Monastir | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06953674 | Jun 2025 → Jun 2029 expected | traumatic brain injury | University of Louisville | Recruiting | No outcome recorded |
| Phase 3 | NCT05962255 | Feb 2022 → Apr 2024 | heart failure | Wroclaw Medical University | Completed | No outcome recorded |
| Phase 3 | NCT05121389 | Jan 2021 → Nov 2022 | ischemic stroke | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT02872155 | Jul 2017 → Jul 2019 | impaired renal function disease | David Garcia Cinca | Completed | No outcome recorded |
| Phase 3 | NCT02875873 | May 2017 → Mar 2020 | acute kidney injury | Hospital do Coracao | Completed | No outcome recorded |
| Phase 3 | NCT02905760 | Dec 2016 → Nov 2018 | acute myocardial infarction | Assistance Publique - Hôpitaux de Paris | Unknown | No outcome recorded |
| Phase 3 | NCT03106922 | Apr 2016 → Jul 2020 | — | Alfasigma S.p.A. | Unknown | No outcome recorded |
| Phase 3 | NCT01786824 | Dec 2014 → Aug 2015 | acute kidney injury, impaired renal function disease | Nîmes University Hospital | Terminated | No outcome recorded |
| Phase 3 | NCT02221024 | Jul 2011 → Sep 2013 | — | IRCCS Burlo Garofolo | Completed | No outcome recorded |
| Phase 3 | NCT01365793 | Nov 2010 → Sep 2016 | brain edema, diabetic ketoacidosis | University of California, Davis | Completed | No outcome recorded |
| Phase 3 | NCT00734214 | Mar 2008 → Dec 2009 | — | Hamilton Health Sciences Corporation | Completed | No outcome recorded |
| Phase 3 | NCT00318942 | Feb 2003 → Aug 2012 | — | University of Versailles | Completed | No outcome recorded |
| Phase 424 trials | ||||||
| Phase 4 | NCT07487831 | Jun 2026 → Mar 2028 expected | atopic eczema, psoriasis | University of California, San Francisco | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07447063 | Jun 2026 → Mar 2028 expected | atopic eczema | University of California, San Francisco | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06242795 | Oct 2024 → Jun 2026 overdue | bronchiectasis | University of North Carolina, Chapel Hill | Recruiting | No outcome recorded |
| Phase 4 | NCT06441162 | Jul 2024 → May 2025 | acute bronchiolitis | NYU Langone Health | Terminated | No outcome recorded |
| Phase 4 | NCT07108881 | May → Dec 2024 | acute hypotension | University Tunis El Manar | Completed | No outcome recorded |
| Phase 4 | NCT06076590 | Nov 2021 → May 2023 | acquired aneurysmal subarachnoid hemorrhage | Capital Medical University | Completed | No outcome recorded |
| Phase 4 | NCT05109000 | Nov 2021 → Jan 2022 | — | Jeffrey Alan Klein, MD | Unknown | No outcome recorded |
| Phase 4 | NCT03880903 | Jul 2020 → Mar 2021 | acute bronchiolitis | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT03068741 | Mar 2020 → Nov 2025 | infectious disease with sepsis | Dr. Damon Scales | Completed | No outcome recorded |
| Phase 4 | NCT04222816 | Jan 2020 → Dec 2021 | bipolar disorder | All India Institute of Medical Sciences, Bhubaneswar | Completed | No outcome recorded |
| Phase 4 | NCT06114459 | Aug 2019 → Mar 2023 | — | Linkoeping University | Completed | No outcome recorded |
| Phase 4 | NCT02435069 | Feb 2016 → Mar 2017 | neurogenic bowel | Nemours Children's Clinic | Completed | No outcome recorded |
| Phase 4 | NCT02542241 | Nov 2015 → Sep 2018 | — | Fundacion Clinica Valle del Lili | Terminated | No outcome recorded |
| Phase 4 | NCT03115060 | Apr 2015 → Apr 2018 | disorder of acid-base balance | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 4 | NCT02209272 | Aug 2014 → Feb 2018 | osteoarthritis, hip | Mayo Clinic | Completed | No outcome recorded |
| Phase 4 | NCT02037815 | Jan → Apr 2014 | brain edema | Capital Medical University | Completed | No outcome recorded |
| Phase 4 | NCT02225431 | Sep 2012 → Apr 2015 | acute kidney injury | Ospedale Misericordia e Dolce | Completed | No outcome recorded |
| Phase 4 | NCT01660867 | Aug 2012 → Dec 2014 | acute bronchiolitis | Seoul National University Hospital | Withdrawn | No outcome recorded |
| Phase 4 | NCT00700375 | Jul 2008 → Mar 2010 | — | Osaka General Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT01016249 | Apr 2007 → Apr 2008 | acute bronchiolitis | Hamad Medical Corporation | Completed | No outcome recorded |
| Phase 4 | NCT00953940 | Jun 2005 → Feb 2011 | — | Hospital Universitario Ramon y Cajal | Terminated | No outcome recorded |
| Phase 4 | NCT03537989 | Nov 1999 → Aug 2001 | — | Holbaek Sygehus | Completed | No outcome recorded |
| Phase 4 | NCT00144820 | May 1999 → Nov 2001 | osteoarthritis, knee | Glostrup University Hospital, Copenhagen | Unknown | No outcome recorded |
| Phase 4 | NCT00493662 | — | dry eye syndrome | Innovative Medical | Completed | No outcome recorded |
| Phase not applicable35 trials | ||||||
| — | NCT07598188 | Jul 2026 → Jan 2027 expected | periapical periodontitis | Islamabad Medical and Dental College | Not yet recruiting | No outcome recorded |
| — | NCT07490808 | Mar → Jul 2026 overdue | acute kidney injury, atrial fibrillation | Beijing Anzhen Hospital | Recruiting | No outcome recorded |
| — | NCT07267897 | Mar → Jun 2026 overdue | — | Sakarya University | Not yet recruiting | No outcome recorded |
| — | NCT07452588 | Feb → Aug 2026 overdue | keratitis | Sohag University | Not yet recruiting | No outcome recorded |
| — | NCT07260240 | Dec 2025 → Mar 2026 | — | Queen Savang Vadhana Memorial Hospital, Thailand | Completed | No outcome recorded |
| — | NCT07486245 | Mar → Nov 2025 | pulpitis | CMH Multan Institute of Medical Sciences | Completed | No outcome recorded |
| — | NCT06022302 | Oct 2023 → Nov 2024 | metabolic disease | University of Copenhagen | Completed | No outcome recorded |
| — | NCT06343493 | Jun → Dec 2023 | chronic rhinosinusitis | Rawalpindi Medical College | Completed | No outcome recorded |
| — | NCT05921695 | May 2023 → Jun 2026 | — | Second Affiliated Hospital, School of Medicine, Zhejiang University | Terminated | No outcome recorded |
| — | NCT05707936 | Feb → Sep 2023 | — | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| — | NCT05980494 | Sep 2022 → May 2024 | infectious disease with sepsis | Fayoum University Hospital | Completed | No outcome recorded |
| — | NCT06950229 | Oct 2020 → Mar 2021 | — | Federal Teaching Hospital Abakaliki | Completed | No outcome recorded |
| — | NCT03685214 | Mar 2019 → Apr 2021 | acute kidney injury, infectious disease with sepsis | ZhiYong Peng | Unknown | No outcome recorded |
| — | NCT03563378 | Jul 2018 → May 2020 | biliary atresia intrahepatic syndromic form | RenJi Hospital | Unknown | No outcome recorded |
| — | NCT03188614 | Aug 2017 → Sep 2018 | — | Southeast University, China | Unknown | No outcome recorded |
| — | NCT04215042 | May 2016 → Dec 2019 | acute kidney injury | Ospedale Misericordia e Dolce | Unknown | No outcome recorded |
| — | NCT03107598 | Mar → Sep 2016 | hypotensive disorder | University Hospital, Mahdia | Terminated | No outcome recorded |
| — | NCT02561325 | Sep 2015 → Jan 2017 | — | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| — | NCT02413125 | Feb → Jun 2015 | sinusitis | University of Virginia | Unknown | No outcome recorded |
| — | NCT02564016 | Oct 2014 → Sep 2016 | pregnancy disorder | Medical University of South Carolina | Terminated | No outcome recorded |
| — | NCT02172092 | Aug 2014 → Dec 2018 | diabetes mellitus | University Hospital, Linkoeping | Completed | No outcome recorded |
| — | NCT02112019 | Jun 2014 → Dec 2017 | Sjogren syndrome | Derk Jan Jager | Unknown | No outcome recorded |
| — | NCT02203123 | Mar 2014 → Apr 2015 | dehydration polycythemia | Seoul National University Hospital | Unknown | No outcome recorded |
| — | NCT02050295 | Feb 2014 → Jan 2018 | — | University of Alberta | Terminated | No outcome recorded |
| — | NCT02045238 | Jul 2013 → Dec 2014 | acute bronchiolitis | University of Sao Paulo | Terminated | No outcome recorded |
| — | NCT01890252 | Jul 2013 → Jan 2014 | corneal edema | Eye-yon Medical | Completed | No outcome recorded |
| — | NCT01823848 | Apr 2013 → Dec 2017 | constipation disorder | Children's Hospital Los Angeles | Terminated | No outcome recorded |
| — | NCT01654328 | Aug 2012 → Oct 2014 | — | Prof. Dr. J. Wetzels | Terminated | No outcome recorded |
| — | NCT01488448 | Nov 2011 → Jul 2014 | bronchiolitis | Montefiore Medical Center | Completed | No outcome recorded |
| — | NCT01449721 | Sep 2011 → Jan 2015 | infectious disease with sepsis | Christiana Care Health Services | Completed | No outcome recorded |
| — | NCT01128413 | Jul 2010 → Nov 2013 | — | Washington University School of Medicine | Terminated | No outcome recorded |
| — | NCT01000350 | Oct 2009 → Jun 2028 expected | postural orthostatic tachycardia syndrome | Vanderbilt University Medical Center | Active not recruiting | No outcome recorded |
| — | NCT01566084 | Feb 2009 → Jan 2012 | hypertensive disorder | University of Colorado, Boulder | Completed | No outcome recorded |
| — | NCT00474162 | May 2007 → Feb 2008 | — | University of British Columbia | Completed | No outcome recorded |
| — | NCT00353340 | Jan 2005 → Jan 2008 | acute kidney injury | Shaare Zedek Medical Center | Completed | No outcome recorded |
Also used as a comparator or background therapy in 178 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 04 trials | ||||||
| Phase 0 | NCT05505708 Comparator | Dec 2022 → Jan 2023 | pulmonary edema | Kasr El Aini Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT03330704 Comparator | Nov 2017 → Jan 2020 | brain edema | Stanford University | Withdrawn | No outcome recorded |
| Phase 0 | NCT03246282 Background | Feb 2017 → Dec 2018 | — | John W. Reeves, MD | Suspended | No outcome recorded |
| Phase 0 | NCT02989571 Comparator | Mar 2016 → Dec 2020 | — | MemorialCare Health System | Completed | No outcome recorded |
| Phase 16 trials | ||||||
| Phase 1 | NCT03340805 Comparator | Jan → Aug 2018 | — | Children's Hospital of Philadelphia | Completed | No outcome recorded |
| Phase 1 | NCT03306589 Background | Aug 2017 → Jan 2018 | rheumatoid arthritis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT03204955 Comparator | Jun 2017 → Sep 2018 | acute kidney injury, subarachnoid hemorrhage | Emory University | Completed | No outcome recorded |
| Phase 1 | NCT03063476 Background | Mar → May 2017 | — | Vanderbilt University Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT03391414 Comparator | Aug 2014 → Jul 2016 | cystic fibrosis | Joseph Pilewski | Completed | No outcome recorded |
| Phase 1 | NCT01223183 Comparator | Sep 2010 → Dec 2012 | cystic fibrosis | University of Pittsburgh | Completed | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT04206943 Background | Oct 2019 → Jan 2021 | acute lymphoblastic leukemia | Acibadem University | Unknown | No outcome recorded |
| Phase 1/2 | NCT02227329 Background | Jul 2014 → Oct 2016 | — | Mayo Clinic | Terminated | No outcome recorded |
| Phase 1/2 | NCT01087853 Comparator | Mar 2010 → Mar 2011 | disorder of acid-base balance, water intoxication | University of Nottingham | Completed | No outcome recorded |
| Phase 1/2 | NCT01547130 Comparator | May 2008 → Dec 2010 | colonic neoplasm | Arya, Vijaypal, M.D., P.C. | Completed | No outcome recorded |
| Phase 224 trials | ||||||
| Phase 2 | NCT05909150 Comparator | Nov 2023 → Mar 2027 expected | acute kidney injury | Fernando Bacal | Recruiting | No outcome recorded |
| Phase 2 | NCT05196581 Comparator | Dec 2021 → Jul 2022 | COVID-19 | Suzana Erico Tanni Minamoto | Completed | No outcome recorded |
| Phase 2 | NCT04842721 Comparator | Jul → Oct 2021 | COVID-19 | Rafik Batroussy | Withdrawn | No outcome recorded |
| Phase 2 | NCT03166228 Comparator | Jan 2018 → Jun 2022 | hypertensive disorder | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT02985060 Background | Nov 2016 → Nov 2017 | ischemic stroke | Seoul National University Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT02632630 Comparator | Mar 2016 → Feb 2018 | nutritional deficiency disease | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 2 | NCT02668952 Comparator | Jan 2016 → Feb 2017 | acute kidney injury | University of New Mexico | Completed | No outcome recorded |
| Phase 2 | NCT02622126 Comparator | Jan → Jul 2016 | blood coagulation disease | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT02707549 Comparator | Aug 2015 → Dec 2016 | brain neoplasm | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 2 | NCT01838863 Comparator | Apr 2014 → Apr 2017 | — | Denver Health and Hospital Authority | Terminated | No outcome recorded |
| Phase 2 | NCT03476460 Comparator | Apr 2014 → Nov 2019 | acute kidney injury, chronic renal failure syndrome, diabetes mellitus, heart failure | Hospital Universitario Ramon y Cajal | Completed | No outcome recorded |
| Phase 2 | NCT02760901 Comparator | Nov 2013 → Oct 2015 | cisplatin toxicity | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT01952470 Comparator | Oct 2013 → Aug 2017 | disease related to solid organ transplantation, respiratory tract infectious disorder | The Alfred | Completed | No outcome recorded |
| Phase 2 | NCT02046135 Comparator | Sep 2013 → Jun 2017 | acute kidney injury, congenital heart disease | Northwell Health | Terminated | No outcome recorded |
| Phase 2 | NCT01619657 Comparator | Jun 2012 → Nov 2016 | cystic fibrosis | Heidelberg University | Completed | No outcome recorded |
| Phase 2 | NCT02276898 Comparator | Nov 2011 → Sep 2014 | cystic fibrosis | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 2 | NCT01285713 Comparator | Sep 2010 → Aug 2011 | — | Children's Hospital of Philadelphia | Completed | No outcome recorded |
| Phase 2 | NCT01573117 Comparator | Sep 2010 → Nov 2011 | hemorrhagic stroke, ischemic stroke | University Hospital Heidelberg | Completed | No outcome recorded |
| Phase 2 | NCT00706771 Comparator | Feb 2010 → Sep 2012 | impaired renal function disease | Austin Health | Completed | No outcome recorded |
| Phase 2 | NCT00696540 Comparator | Jun → Sep 2008 | bronchiolitis | University Diego Portales | Unknown | No outcome recorded |
| Phase 2 | NCT00575484 Comparator | Nov 2007 → Jul 2008 | congestive heart failure, impaired renal function disease | Barnes-Jewish Hospital | Terminated | No outcome recorded |
| Phase 2 | NCT00540904 Comparator | Sep 2007 → Aug 2008 | — | Barretos Cancer Hospital | Completed | No outcome recorded |
| Phase 2 | NCT00583466 Comparator | May 2007 → May 2008 | gastrointestinal polyp | Johns Hopkins University | Completed | No outcome recorded |
| Phase 2 | NCT00308152 Comparator | Feb 2006 → May 2008 | colonic disorder | The Canberra Hospital | Completed | No outcome recorded |
| Phase 2/38 trials | ||||||
| Phase 2/3 | NCT05869565 Comparator | Feb 2023 → Feb 2024 | stroke disorder | Aga Khan University | Unknown | No outcome recorded |
| Phase 2/3 | NCT02950883 Comparator | Mar 2015 → Dec 2020 | cystic fibrosis | University of Washington, the Collaborative Health Studies Coordinating Center | Completed | No outcome recorded |
| Phase 2/3 | NCT02752308 Comparator | Sep 2014 → Mar 2015 | hypospadias | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT02088502 Comparator | Sep 2013 → Apr 2014 | — | Isfahan University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2/3 | NCT02114346 Background | Jul 2013 → Feb 2014 | — | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT00995683 Comparator | Jun 2009 → May 2011 | traumatic brain injury | Institut d'Anesthesiologie des Alpes Maritimes | Completed | No outcome recorded |
| Phase 2/3 | NCT00130598 Comparator | Jun 2005 → Dec 2009 | acute kidney injury | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 2/3 | NCT00878631 Comparator | Sep 2004 → Jan 2006 | traumatic brain injury | Unity Health Toronto | Completed | No outcome recorded |
| Phase 334 trials | ||||||
| Phase 3 | NCT07497542 Comparator | Apr 2026 → Aug 2029 expected | brain infarction | Tianjin Medical University General Hospital | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06020495 Background | Dec 2024 → Sep 2026 expected | — | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
| Phase 3 | NCT06030609 Comparator | Sep 2024 → Feb 2026 | disorder of acid-base balance | King Chulalongkorn Memorial Hospital | Completed | No outcome recorded |
| Phase 3 | NCT06545565 Comparator | Jul 2024 → May 2025 overdue | metabolic acidosis | Aga Khan University Hospital, Pakistan | Recruiting | No outcome recorded |
| Phase 3 | NCT06363877 Comparator | Jun 2024 → Oct 2026 expected | — | Loma Linda University | Recruiting | No outcome recorded |
| Phase 3 | NCT05752279 Comparator | Mar 2024 → Jul 2026 overdue | diabetic ketoacidosis | The George Institute | Recruiting | No outcome recorded |
| Phase 3 | NCT02686151 Background | Dec 2023 → Mar 2024 | ovarian hyperstimulation syndrome | The Affiliated Hospital of Inner Mongolia Medical University | Unknown | No outcome recorded |
| Phase 3 | NCT05355974 Background | Aug 2022 → Jul 2024 | hypotensive disorder, orthostatic hypotension 2, respiratory failure | Wright State University | Completed | No outcome recorded |
| Phase 3 | NCT04102371 Comparator | Aug 2020 → Dec 2025 | — | Children's Hospital of Philadelphia | Completed | No outcome recorded |
| Phase 3 | NCT03630224 Comparator | Jun 2019 → Aug 2023 | acute kidney injury | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 3 | NCT03829488 Comparator | Jan 2018 → Jul 2021 | end stage renal failure | The University of Queensland | Completed | No outcome recorded |
| Phase 3 | NCT03277677 Comparator | Jul 2017 → Jul 2018 | acute kidney injury, infectious disease with sepsis | Chulalongkorn University | Completed | No outcome recorded |
| Phase 3 | NCT03054922 Comparator | Feb 2017 → Sep 2018 | — | Nationwide Children's Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02402049 Comparator | Mar 2015 → Mar 2016 | premenstrual tension | Shaare Zedek Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT02980003 Comparator | Mar 2015 → Oct 2020 | acute kidney injury | G. d'Annunzio University | Completed | No outcome recorded |
| Phase 3 | NCT02336620 Comparator | Dec 2014 → Jan 2017 | infectious disease with sepsis | Ramathibodi Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02280473 Comparator | Nov 2014 → Mar 2015 | dry eye syndrome | Allergan | Completed | No outcome recorded |
| Phase 3 | NCT02641561 Comparator | Oct 2014 → Jun 2016 | acute pancreatitis | The Cooper Health System | Completed | No outcome recorded |
| Phase 3 | NCT01467466 Comparator | Oct 2013 → Sep 2017 | acute kidney injury, coronary artery disorder | VA Office of Research and Development | Completed | No outcome recorded |
| Phase 3 | NCT01909336 Comparator | Jul 2013 → Feb 2014 | — | Instituto Tecnologico y de Estudios Superiores de Monterey | Completed | No outcome recorded |
| Phase 3 | NCT01812525 Comparator | Mar 2013 → Apr 2016 | acute bronchiolitis | Raphaelle Jaquet-Pilloud | Completed | No outcome recorded |
| Phase 3 | NCT01271114 Comparator | Jun 2012 → Dec 2013 | infectious disease with sepsis | Hospital General de Ciudad Real | Terminated | No outcome recorded |
| Phase 3 | NCT01636089 Comparator | Feb 2012 → Jan 2015 | acute kidney injury | University Hospital, Caen | Completed | No outcome recorded |
| Phase 3 | NCT01111682 Comparator | Apr → Nov 2010 | intracranial hypertension, traumatic brain injury | University of Cincinnati | Terminated | No outcome recorded |
| Phase 3 | NCT00935168 Comparator | Dec 2009 → Apr 2012 | — | The George Institute | Completed | No outcome recorded |
| Phase 3 | NCT01210456 Comparator | Oct 2009 → Oct 2014 | chronic kidney disease | Tokushukai Medical Group | Unknown | No outcome recorded |
| Phase 3 | NCT00796354 Comparator | Nov 2008 → Feb 2010 | constipation disorder | Norgine | Completed | No outcome recorded |
| Phase 3 | NCT00847977 Comparator | Oct 2008 → Oct 2010 | traumatic brain injury | Nantes University Hospital | Terminated | No outcome recorded |
| Phase 3 | NCT00702728 Comparator | Jun 2008 → Jun 2009 | acute tubulointerstitial nephritis | Centro Cardiologico Monzino | Unknown | No outcome recorded |
| Phase 3 | NCT00632775 Comparator | Dec 2007 → Sep 2012 | — | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT00514150 Comparator | Aug 2007 → Jun 2008 | acute tubulointerstitial nephritis | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Phase 3 | NCT00457873 Comparator | Jan 2007 → Apr 2008 | bronchiolitis, gastroenteritis, infectious disease with sepsis, urinary tract infection | McGill University Health Centre/Research Institute of the McGill University Health Centre | Completed | No outcome recorded |
| Phase 3 | NCT00522756 Comparator | May 2006 → Dec 2012 | acute kidney injury | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| Phase 3 | NCT00799916 Comparator | Jan 2006 → Aug 2009 | infectious disease with sepsis | National University of La Plata | Completed | No outcome recorded |
| Phase 443 trials | ||||||
| Phase 4 | NCT07437339 Comparator | Mar 2026 → Dec 2027 expected | — | Inova Health Care Services | Recruiting | No outcome recorded |
| Phase 4 | NCT06541535 Comparator | Nov 2025 → Dec 2027 expected | diabetic ketoacidosis | Centre Hospitalier Universitaire de Nice | Recruiting | No outcome recorded |
| Phase 4 | NCT07035509 Comparator | Jul 2025 → Jul 2026 overdue | infectious disease with sepsis | Fundación Cardioinfantil Instituto de Cardiología | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07286526 Comparator | Aug 2024 → Mar 2025 | acute kidney injury | Yunus Emre Gemici | Completed | No outcome recorded |
| Phase 4 | NCT06374823 Comparator | May 2024 → Dec 2026 expected | critical illness polyneuropathy, hemorrhagic stroke | Capital Medical University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05781243 Comparator | Jun 2023 → Sep 2024 | acute pancreatitis | Enrique de-Madaria | Completed | No outcome recorded |
| Phase 4 | NCT05808972 Comparator | Nov 2022 → Dec 2023 | diabetic ketoacidosis | Tunis University | Completed | No outcome recorded |
| Phase 4 | NCT04680936 Comparator | Jan 2021 → May 2022 | epicondylitis | Ahi Evran University Education and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04213508 Comparator | Feb 2020 → Jan 2021 | sinusitis | Imam Abdulrahman Bin Faisal University | Unknown | No outcome recorded |
| Phase 4 | NCT04243655 Background | Dec 2019 → Oct 2020 | liver disorder | Asian Institute of Gastroenterology, India | Unknown | No outcome recorded |
| Phase 4 | NCT03961048 Background | Jul 2019 → Sep 2020 | — | Virginia Commonwealth University | Withdrawn | No outcome recorded |
| Phase 4 | NCT03066440 Comparator | Sep 2018 → Mar 2024 | diabetic ketoacidosis | State University of New York at Buffalo | Terminated | No outcome recorded |
| Phase 4 | NCT03529097 Comparator | Jun 2018 → Dec 2019 | urinary tract obstruction | Sheba Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT03280745 Comparator | Feb 2018 → May 2019 | cardiac valvular defect, cardiovascular disorder | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
| Phase 4 | NCT02721654 Comparator | Sep 2017 → Mar 2021 | — | The George Institute | Completed | No outcome recorded |
| Phase 4 | NCT03420261 Comparator | Aug 2017 → Jul 2018 | — | University Hospital, Clermont-Ferrand | Completed | No outcome recorded |
| Phase 4 | NCT03070847 Background | Mar 2017 → Mar 2019 | — | Bartłomiej Wódarski | Unknown | No outcome recorded |
| Phase 4 | NCT03011632 Background | Jan 2017 → Aug 2019 | asthma, chronic rhinosinusitis | Medical University of Lodz | Completed | No outcome recorded |
| Phase 4 | NCT03627884 Comparator | Oct 2016 → Mar 2018 | acute kidney injury, end stage renal failure | Coney Island Hospital, Brooklyn, NY | Completed | No outcome recorded |
| Phase 4 | NCT04512950 Comparator | Aug 2016 → Jun 2020 | — | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT02590081 Comparator | Oct 2015 → Oct 2016 | end stage renal failure | Penang Hospital, Malaysia | Unknown | No outcome recorded |
| Phase 4 | NCT02421419 Comparator | Jun 2015 → Jan 2017 | tendon sheath disorder | Kenneth Taylor, M.D. | Terminated | No outcome recorded |
| Phase 4 | NCT02528448 Comparator | Mar 2015 → Feb 2016 | poisoning | Regional Hospital Holstebro | Unknown | No outcome recorded |
| Phase 4 | NCT02084771 Comparator | Oct 2014 → Dec 2015 | acute kidney injury | Ottawa Hospital Research Institute | Withdrawn | No outcome recorded |
| Phase 4 | NCT01491243 Comparator | Jan 2014 → Dec 2015 | coronary artery disorder | University of Roma La Sapienza | Unknown | No outcome recorded |
| Phase 4 | NCT01939145 Comparator | Sep 2013 → Jul 2014 | skin infection | Georgetown University | Completed | No outcome recorded |
| Phase 4 | NCT02233985 Comparator | Aug 2013 → Feb 2017 | acute bronchiolitis, asthma | Coordinación de Investigación en Salud, Mexico | Completed | No outcome recorded |
| Phase 4 | NCT01692769 Comparator | May 2013 → Aug 2014 | brain injury | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 4 | NCT01611324 Comparator | May → Dec 2012 | varicose disease | Campus-Bio-Medico University | Completed | No outcome recorded |
| Phase 4 | NCT01782573 Comparator | Oct 2011 → Sep 2012 | liver and intrahepatic bile duct neoplasm | Changhua Christian Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01234883 Comparator | Jun 2011 → Feb 2013 | gastroenteritis | Baxter Healthcare Corporation | Terminated | No outcome recorded |
| Phase 4 | NCT01742130 Comparator | Jan 2011 → Oct 2013 | acute kidney injury | Ospedale Misericordia e Dolce | Completed | No outcome recorded |
| Phase 4 | NCT01871857 Comparator | Nov 2010 → Aug 2012 | acute bronchiolitis | Le Bonheur Children's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01795638 Comparator | Oct 2009 → Jan 2011 | — | Children's Hospital Medical Center, Cincinnati | Terminated | No outcome recorded |
| Phase 4 | NCT00950079 Comparator | Feb 2008 → Aug 2009 | acute tubulointerstitial nephritis | CardioVascular Research Foundation, Korea | Unknown | No outcome recorded |
| Phase 4 | NCT00639912 Comparator | Jun 2007 → May 2010 | — | Azienda USL Reggio Emilia - IRCCS | Completed | No outcome recorded |
| Phase 4 | NCT00384995 Comparator | Dec 2006 → Jul 2009 | acute kidney injury | Italian Society of Nephrology | Terminated | No outcome recorded |
| Phase 4 | NCT00392145 Comparator | Nov 2006 → May 2010 | gastroenteritis | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 4 | NCT00377403 Background | Oct 2006 → May 2009 | respiratory tract infectious disorder, sinusitis | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT00273728 Comparator | May 2005 → Jun 2010 | infectious disease with sepsis | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 4 | NCT00606827 Comparator | Jan 2005 → Mar 2006 | — | Ospedale Misericordia e Dolce | Completed | No outcome recorded |
| Phase 4 | NCT00770614 Comparator | Mar 2004 → Jun 2008 | acute tubulointerstitial nephritis | Ospedale Misericordia e Dolce | Completed | No outcome recorded |
| Phase 4 | NCT00749827 Comparator | — | acute tubulointerstitial nephritis | Memorial University of Newfoundland | Withdrawn | No outcome recorded |
| Phase not applicable55 trials | ||||||
| — | NCT07550790 Comparator | Jul 2026 → Jun 2027 expected | heart failure, impaired renal function disease | Jin Joo Park | Recruiting | No outcome recorded |
| — | NCT07385560 Background | Feb → May 2026 overdue | osteoarthritis, knee, popliteal cyst | Istanbul University - Cerrahpasa | Not yet recruiting | No outcome recorded |
| — | NCT07202559 Comparator | Oct 2025 → Dec 2027 expected | acute pancreatitis, chronic pancreatitis | Changhai Hospital | Recruiting | No outcome recorded |
| — | NCT07188766 Comparator | Oct 2025 → Aug 2028 expected | vascular occlusion disorder | Imam Abdulrahman Bin Faisal University | Recruiting | No outcome recorded |
| — | NCT07647575 Comparator | Oct 2025 → Apr 2028 expected | bronchiectasis, pulmonary non-tuberculous mycobacterial infection | Taipei Veterans General Hospital, Taiwan | Recruiting | No outcome recorded |
| — | NCT07138625 Comparator | Oct 2025 → Mar 2026 overdue | acute bronchiolitis | University Of Anbar | Not yet recruiting | No outcome recorded |
| — | NCT07503574 Comparator | Apr → Jul 2025 | myofascial pain syndrome | Ankara University | Completed | No outcome recorded |
| — | NCT06848894 Background | Mar 2025 → Dec 2026 expected | ischemic stroke | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07167797 Comparator | Jan → May 2025 | Rotavirus infection | University of Baghdad | Completed | No outcome recorded |
| — | NCT06339203 Comparator | Jun 2024 → Dec 2026 expected | — | Loma Linda University | Recruiting | No outcome recorded |
| — | NCT05772234 Comparator | Nov 2023 → Mar 2025 | chronic pancreatitis | Changhai Hospital | Completed | No outcome recorded |
| — | NCT06158555 Background | Apr 2023 → Jun 2024 | — | King's College Hospital NHS Trust | Unknown | No outcome recorded |
| — | NCT04043598 Comparator | May 2022 → Jul 2027 expected | subarachnoid hemorrhage | Insel Gruppe AG, University Hospital Bern | Recruiting | No outcome recorded |
| — | NCT05209841 Comparator | Apr 2022 → Jul 2026 overdue | — | Consorci Sanitari de l'Alt Penedès i Garraf | Recruiting | No outcome recorded |
| — | NCT05194761 Comparator | Oct 2021 → Jul 2022 | neonatal respiratory failure | Ain Shams University | Unknown | No outcome recorded |
| — | NCT04621981 Comparator | Mar 2021 → Sep 2022 | infectious disease with sepsis | Xiangya Hospital of Central South University | Unknown | No outcome recorded |
| — | NCT05264584 Background | Dec 2020 → Sep 2021 | chronic kidney disease | Ain Shams University | Completed | No outcome recorded |
| — | NCT04137042 Comparator | Mar 2020 → May 2021 | — | National Taiwan University Hospital | Completed | No outcome recorded |
| — | NCT04492150 Background | Sep 2019 → Sep 2020 | — | Suez Canal University | Unknown | No outcome recorded |
| — | NCT05914896 Comparator | Apr 2019 → Jun 2020 | acute kidney injury | Umeå University | Completed | No outcome recorded |
| — | NCT03591172 Comparator | Sep → Nov 2018 | — | Cairo University | Unknown | No outcome recorded |
| — | NCT03954860 Background | Aug 2018 → Sep 2019 | osteoarthritis, knee | Qilu Hospital of Shandong University | Completed | No outcome recorded |
| — | NCT05953675 Comparator | Aug 2018 → Dec 2024 | — | Zealand University Hospital | Unknown | No outcome recorded |
| — | NCT03533777 Background | Jun 2018 → Jun 2019 | — | University of Iowa | Completed | No outcome recorded |
| — | NCT03948230 Comparator | Jan 2018 → Jul 2019 | — | Swansea University | Unknown | No outcome recorded |
| — | NCT03371199 Comparator | Dec 2017 → Dec 2018 | metabolic bone disorder | Rigshospitalet, Denmark | Completed | No outcome recorded |
| — | NCT03215862 Comparator | Aug 2017 → Aug 2018 overdue | acute pancreatitis | University of South Florida | Not yet recruiting | No outcome recorded |
| — | NCT02835157 Comparator | Apr 2017 → Jan 2020 | infectious disease with sepsis | All India Institute of Medical Sciences | Completed | No outcome recorded |
| — | NCT03048162 Comparator | Feb → May 2017 | — | Tokat Gaziosmanpasa University | Completed | No outcome recorded |
| — | NCT02726620 Background | Jan → Dec 2017 | hypotensive disorder | Vanderbilt University Medical Center | Completed | No outcome recorded |
| — | NCT02718521 Background | Mar 2016 → Mar 2017 | cardio-renal syndrome | Chinese PLA General Hospital | Unknown | No outcome recorded |
| — | NCT02660151 Background | Feb 2016 → Oct 2018 | corneal edema | Eye-yon Medical | Completed | No outcome recorded |
| — | NCT03136458 Background | Jan 2016 → Oct 2018 | — | Camilo Andrés Páez Angarita | Withdrawn | No outcome recorded |
| — | NCT02822131 Background | Jan → Jun 2016 | hypertensive disorder | University of Zurich | Completed | No outcome recorded |
| — | NCT02383992 Comparator | Oct 2015 → Oct 2019 | — | Northwestern University | Withdrawn | No outcome recorded |
| — | NCT02530346 Comparator | Oct 2015 → Dec 2019 | — | Hospital Infantil de Mexico Federico Gomez | Unknown | No outcome recorded |
| — | NCT02378467 Comparator | Mar 2015 → Aug 2018 | cystic fibrosis | University of Washington, the Collaborative Health Studies Coordinating Center | Completed | No outcome recorded |
| — | NCT02476448 Comparator | Feb 2015 → Feb 2016 | ureteral disorder | Cecilia Calvo | Completed | No outcome recorded |
| — | NCT02305199 Comparator | Jan 2015 → Apr 2017 | type 2 diabetes mellitus | Yeungnam University College of Medicine | Withdrawn | No outcome recorded |
| — | NCT02785133 Background | Dec 2014 → Oct 2016 | — | UVLrx Therapeutics | Completed | No outcome recorded |
| — | NCT02520804 Comparator | Nov 2014 → Jun 2017 | acute kidney injury | Mahidol University | Unknown | No outcome recorded |
| — | NCT03956446 Background | Sep 2014 → Dec 2027 expected | tick-borne encephalitis | University Medical Centre Ljubljana | Recruiting | No outcome recorded |
| — | NCT02782819 Comparator | Sep 2014 → Aug 2018 | hypotensive disorder | Mahidol University | Unknown | No outcome recorded |
| — | NCT02067195 Comparator | Jul 2014 → Mar 2016 | ST-elevation myocardial infarction | Guangdong Provincial People's Hospital | Unknown | No outcome recorded |
| — | NCT02405377 Background | Feb 2014 → Feb 2015 | cardio-renal syndrome | Chinese PLA General Hospital | Completed | No outcome recorded |
| — | NCT02462902 Comparator | Feb 2014 → Jun 2015 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT01722422 Comparator | Oct 2012 → Sep 2014 | adult acute respiratory distress syndrome, infectious disease with sepsis | University Hospital, Angers | Terminated | No outcome recorded |
| — | NCT01585740 Comparator | Sep 2011 → Apr 2012 | metabolic acidosis | Makerere University | Completed | No outcome recorded |
| — | NCT01882920 Comparator | Jun 2010 → Jun 2012 | peritoneal neoplasm | Regina Elena Cancer Institute | Completed | No outcome recorded |
| — | NCT01066624 Comparator | Aug 2009 → Jan 2014 | chemotherapy-induced oral mucositis, plasma cell myeloma | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
| — | NCT00964015 Comparator | Aug 2009 → Jun 2010 | — | London Health Sciences Centre | Terminated | No outcome recorded |
| — | NCT00924404 Comparator | May 2009 → Aug 2014 | chronic rhinosinusitis | University of Iowa | Completed | No outcome recorded |
| — | NCT00709280 Comparator | Apr 2009 → Oct 2011 | cystic fibrosis | CF Therapeutics Development Network Coordinating Center | Completed | No outcome recorded |
| — | NCT00608790 Background | Feb 2008 → Dec 2012 | tuberculosis | University of Cape Town | Unknown | No outcome recorded |
| — | NCT01972828 Background | Jul 2007 → Aug 2013 | infectious disease with sepsis | Hospices Civils de Lyon | Completed | No outcome recorded |
Evidence & citations 37 cited values
Every value below carries the sentence it was read from. 282 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium chloride | “Following aspiration, an injection mixture consisting of 1 mL betamethasone,
1 mL of 2% lidocaine, and 1 mL of 0.9% isotonic sodium chloride is administered into the...” NCT07385560 ↗121“The aim of this study is to determine whether sodium bicarbonate is superior to sodium chloride in preventing contrast induced nephropathy in diabetic patients undergoing...” NCT00950079 ↗ “Treatment of the metabolic alkalosis with volume and sodium chloride (NaCl) replacement could reduce hypoventilation and hypercapnia, thereby improving symptoms, sleep patterns...” NCT00163852 ↗ “3% and 5% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution for fluid and electrolyte replenishment in single dose containers for intravenous...” NCT04147182 ↗ “The Active Rinse is a 25 ml of Hypertonic Saturated Saline solution made by mixing 10 grams of Sodium Chloride (Table Salt) in 25 ml of Tap water with some salt crystals deposited.” NCT04842721 ↗ “0.9 percent sodium chloride will be administered via IV route to all subjects at a rate of 250 mL/hour for 4 hours prior to dosing with LPS and 8 hours after dosing with LPS.” NCT03306589 ↗ “Patients received 4 mL of 3% sodium chloride (hypertonic saline [HS group]) or 0.9% sodium chloride (normal saline [NS group]) inhaled as many as 3 times in the ED.” PMID 24862623 ↗ Jul 2014 “Patients were randomized to receive intravenous volume supplementation with either (A) sodium chloride 0.9% 1 mL/kg/h for at least 12h prior and after the procedure” PMID 22267245 ↗ Jan 2012 “0.9 % sodium chloride (NaCl) intravenous (IV) fluid replacement in children with moderate to severe dehydration secondary to acute gastroenteritis (AGE).” PMID 27480410 ↗ Aug 2016 “randomized to receive a 154-mEq/L infusion of either sodium chloride (n = 59) or sodium bicarbonate (n = 60) before and after iopamidol administration” PMID 15150204 ↗ May 2004 “The coload group received a sodium chloride 0.9% perfusion as rapidly as possible starting at the time of intrathecal injection for spinal anesthesia.” NCT03107598 ↗ “Standard treatment for rotavirus which includes rehydration therapy and antipyretic therapy including sodium chloride fluid and paracetamol infusion” NCT07167797 ↗ “Most nasal irrigations use normal saline (0.9% sodium chloride), which approximates the physiological concentration of plasma in the blood.” NCT02413125 ↗ “prime solution containing Ringer-Acetate 1000 ml + Mannitol 400 ml (60 g) + Sodium-Chloride 40 ml (160 mmol) and Heparin 2 ml (10 000 IU)” NCT05914896 ↗ “prepared from sodium chloride 0.9% intravenous solution and sodium chloride 3% intravenous solution (, Egypt Otsuka Pharmaceutical Co.).” NCT04785755 ↗ “Lidocaine-saline group were injected with 2 ml of lidocaine hydrochloride (20 mg/ml) and 6 ml of a 0.9% sodium chloride mixture.” NCT07503574 ↗ “large quantity of ice-cold saline (0.9% Sodium Chloride for Injection USP) will be pumped as rapidly as possible into the aorta” NCT01042015 ↗ “Sachet B: sodium citrate 1.863 g, anhydrous citric acid 0.813 g, sodium chloride 0.730 g, potassium chloride 0.370 g;” NCT03106922 ↗ “Patients were randomised to receive standard SC with nebulisation of 4 mL of 3% sodium chloride every 6 hours” PMID 31488402 ↗ Sep 2019 “NSCLS contained 0.9% sodium chloride at a pH 4.5-7.0, and was used to lock NSCLS-group patient catheters.” NCT03627884 ↗ “4 mL mepivacaine chlorhydrate 20 mg/mL with epinephrine 5 mcg/mL diluted with 16 mL sodium chloride 0.9%” NCT01611324 ↗ “Tranexamic Acid would be diluted in 0,9% Sodium Chloride (0,9% NaCl) to cumulative volume of 20 ml.” NCT03070847 ↗ “supplemental 3ml 0.9% Sodium chloride (NaCl) solution in a nasal nebuliser once a day for 3 months” NCT03011632 ↗ “0.9% sodium chloride at 1 ml/kg/h is administered via a slow intravenous perfusion.” NCT01786824 ↗ “Isotonic Saline (0.9% sodium chloride) 1 mL/kg/h for 12 hours after the procedure” NCT00770614 ↗ “normal salt' condition (2300 mg sodium chloride pills + 1200 mg dietary sodium)” NCT01566084 ↗ “300mg sodium chloride consumed in a capsule on two occasions with 300ml water” NCT03948230 ↗ “HUK (0.15 PNA) and sodium chloride injection (100ml), once per day” NCT06848894 ↗ “Sodium Chloride 3% solution, previously prepared in 5 mL syringes.” NCT02045238 ↗ “Intravenous fluid resuscitation with saline (0.9% sodium chloride)” NCT00935168 ↗ “saline injection contains 0.9% isotonic sodium chloride solution” NCT04197245 ↗ “Both arms were treated with 5% sodium chloride 6 times a day.” PMID 33014443 ↗ Sep 2020 “effectiveness of inhaled sodium chloride therapy (BREATHOX®)” NCT05196581 ↗ “0.9% sodium chloride solution 2000 ml / day i.v. infusion” NCT04206943 ↗ “Catheters will be sealed with 3mL of 0.9% sodium chloride” NCT05209841 ↗ “154mEq/L of sodium chloride is given intravenously.” NCT01210456 ↗ “0.9% sodium chloride solution, Glycerol, Glycerin” NCT02435069 ↗ “PARI Hyper-Sal™ Sodium Chloride Solution - 7%” NCT02276898 ↗ “Fluid expansion, Sodium Chloride NaCl 0.9%.” NCT02905760 ↗ “250 ml of 0.9% Sodium Chloride Solution” NCT03246282 ↗ “150 ml of 0.9% Sodium Chloride Solution” NCT02785133 ↗ “0.9% Sodium chloride intravenous fluid” NCT01449721 ↗ “Sodium Chloride (NaCl) 2.6 g. per os” NCT04802785 ↗ “sodium chloride 3% 150ml for 20 min” NCT06020495 ↗ “0.45% Sodium Chloride/5% dextrose” NCT00632775 ↗ “intravenous 0.9% sodium chloride” PMID 29130810 ↗ Nov 2017 “saline (0.9% sodium chloride)” NCT06076590 ↗ “sodium chloride 0,9%” NCT01636089 ↗ “7% sodium chloride” NCT06242795 ↗ “sodium Chloride” NCT06545565 ↗ |
| Known as | 0.9 % Normal Saline | “A 20 mL/kg 0.9% normal saline bolus (maximum 999 mL) will be administered over 1 hour.” NCT00392145 ↗ |
| Known as | 0.9% NaCl | “After postoperative admission to the intensive care unit (ICU), patients will be randomly assigned to receive 5 ml/kg ideal body weight HS (7.3% NaCl) or normal saline (NS,...” PMID 31200756 ↗ Jun 20196“Normal saline (0.9% NaCl) is an isotonic solution that is widely used for intravenous application but is also used as our SOC for wound irrigation.” NCT01939145 ↗ “Sodium chloride (0.9%) referred as 0.9% NaCl for 72 hours post symptom onset (60-72 hourspost randomization)” NCT05869565 ↗ “Tranexamic Acid would be diluted in 0,9% Sodium Chloride (0,9% NaCl) to cumulative volume of 20 ml.” NCT03070847 ↗ “Normal Saline (0.9% NaCl)” NCT06953674 ↗ |
| Known as | 0.9% saline | “In Phase A, 12 subjects will receive 2 litres of 0.9% saline BP (Baxter Health Care, Thetford, UK) or Plasmalyte® (Baxter Health Care, Thetford, UK).” NCT01087853 ↗7“A total of 1500 ml 0.9% saline hydration therapy was administered over 2.5 hours.” NCT07286526 ↗ “Drug : ringer lactate, 0.9% saline, VOLUVEN ®” NCT01972828 ↗ |
| Known as | 0.9% sodium chloride | “Participants assigned to the hydration group will receive 0.9% sodium chloride intravenously at 2 mL/kg/h starting when the participant enters the electrophysiology laboratory...” NCT07490808 ↗7“saline (0.9% sodium chloride)” PMID 28651514 ↗ Jun 2017 |
| Known as | 0.9% Sodium Chloride for Injection USP | “large quantity of ice-cold saline (0.9% Sodium Chloride for Injection USP) will be pumped as rapidly as possible into the aorta” NCT01042015 ↗ |
| Known as | 0.9% Sodium Chloride Saline | “Isotonic Saline ( 0.9% Sodium Chloride Saline)” NCT04213508 ↗ |
| Known as | 0.9% sodium chloride solution | “normal saline (0.9% sodium chloride solution)” NCT02590081 ↗ |
| Known as | 3% Sodium Chloride Saline | “Hypertonic Saline ( 3% Sodium Chloride Saline)” NCT04213508 ↗ |
| Known as | bacteriostatic saline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02209272 ↗ |
| Known as | hypersel | “Hypertonic saline at the concentration of 3% (hypersel) has been injected for years into echinococcal cysts to kill live scolices” NCT04147182 ↗ |
| Known as | Hypertonic Saline | “Patients will receive inhaled Hypertonic Saline 3%, initially with a 2 hour interval, and clinical evaluation prior to each inhalation.” NCT02045238 ↗1“Hypertonic Saline ( 3% Sodium Chloride Saline)” NCT04213508 ↗ |
| Known as | isotonic saline | “Isotonic saline (NaCl 0.9%), called "physiological serum" is the standard fluid for the resuscitation of severely injured patients.” NCT03630224 ↗ |
| Known as | isotonic saline solution | “isotonic saline solution infusion (fluid preloading) to achieve correction of hypovolemia before spinal anesthesia using cardiac ultrasoud guidance by measurment of VTI...” NCT07108881 ↗ |
| Known as | MOVICOL | “one sacket of Movicol powder (13 g macrogol 3350)” NCT06022302 ↗ |
| Known as | NaCl | “Treatment of the metabolic alkalosis with volume and sodium chloride (NaCl) replacement could reduce hypoventilation and hypercapnia, thereby improving symptoms, sleep patterns...” NCT00163852 ↗10“dispersible NaCl powder, 8 mg per session per hour (one administration in each nostril and two oral inhalations)” NCT05196581 ↗ “supplemental 3ml 0.9% Sodium chloride (NaCl) solution in a nasal nebuliser once a day for 3 months” NCT03011632 ↗ “0.9% Sodium Chloride (NaCl) saline will be used as nasal irrigation for two groups.” NCT04213508 ↗ “50 mL of 10% hypertonic sodium chloride (NaCl)” NCT07596329 ↗ “Sodium Chloride (NaCl) 0.9 %” NCT07188766 ↗ “0.9 % sodium chloride (NaCl)” PMID 27480410 ↗ Aug 2016 “Normal Saline (0.9% NaCl)” NCT07486245 ↗ |
| Known as | NaCl 0.9% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03630224 ↗ |
| Known as | Natrum muriaticum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02402049 ↗ |
| Known as | Normal (0.9%) saline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01547130 ↗ |
| Known as | normal saline | “Drug: 0.9% Isotonic Saline (IS) 4 mL of IS will be administered via inhalation twice daily for 48 weeks The delivery system is the same as that for the test product.
Other...” NCT02950883 ↗83“The purpose of this study is to compare a large volume ACE flush using a salt water solution called normal saline with a small volume ACE flush using liquid glycerin.” NCT02435069 ↗ “Patient will receive normal saline or Ringer lactate or other balance salt solution during fluid resuscitation for shock reversal.” NCT02782819 ↗ “Normal saline will be give to subjects in the standard arm as the current standard of care for an initial resuscitation fluid” NCT01838863 ↗ “Basal infusion of crystalloid (normal saline,Ringer's lactate,Ringer's solution)variable from 4 to 12 ml/kg/hour.” NCT01882920 ↗ “The placebo group is resuscitated with normal saline, the experimental group is resuscitated with balanced fluid.” NCT03188614 ↗ “0.9% Normal Saline (0.9% Sodium Chloride) injection intravenously as needed.” NCT02668952 ↗ “stoma enemas (20mlkgdo of normal saline 3 times a day) will be prescribed” NCT02530346 ↗ “0.9% normal saline infusion and boluses of mannitol” NCT01111682 ↗ “normal saline, dextrose, lactated Ringer's” NCT02632630 ↗ “Drug: Normal saline” NCT05209841 ↗ |
| Known as | normal saline solution | “The aim of this study was to show that 6% hydroxyethyl starch (HES) 130/0.4 achieves a better resuscitation of the microcirculation than normal saline solution (SS), during...” PMID 20813485 ↗ Sep 20103“Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W)” NCT06030609 ↗ “normal saline solution (0.9% sodium chloride)” NCT02707549 ↗ “Drug: Normal Saline Solution” NCT02785133 ↗ |
| Known as | Normal saline. Isotonic saline. Sodium Chloride 0.9% . | “Normal saline. Isotonic saline. Sodium Chloride 0.9% .” NCT00639912 ↗ |
| Known as | NSS | “Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W)” NCT06030609 ↗ |
| Known as | PARI Hyper-Sal | “PARI Hyper-Sal™ Sodium Chloride Solution - 7%” NCT02276898 ↗ |
| Known as | physiological saline | “physiological saline 20 mL (distention)” PMID 18415773 ↗ Mar 2008 |
| Known as | physiological serum | “Physiological serum: basic flow 30 ml/kg/j during 48 hoursand boli wished by physicians 20 ml/kg on 20 minutes Heafusine: boli 10 ml/kg on 20 minutes” NCT00847977 ↗1“Isotonic saline (NaCl 0.9%), called "physiological serum" is the standard fluid for the resuscitation of severely injured patients.” NCT03630224 ↗ |
| Known as | REFRESH LIQUIGEL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02280473 ↗ |
| Known as | saline | “Paramedics will administer up to 2 litres of intravenous saline (0.9%) to all patients regardless of systolic blood pressure, and reassessing this infusion after each 250ml are infused.” NCT03068741 ↗30“Isotonic or hypertonic saline or Ringer Lactate or any other crystalloids, at the necessary dose to restore hemodynamic for all ICU stay” NCT00318942 ↗ “Two types of fluids are commonly used. One is a salt water solution (saline) and the other is a starch water solution (pentastarch).” NCT00474162 ↗ “large quantity of ice-cold saline (0.9% Sodium Chloride for Injection USP) will be pumped as rapidly as possible into the aorta” NCT01042015 ↗ “Sodium chloride (0.9% saline) infusion is a sterile, non-pyrogenic solution of sodium chloride in Water for Injections.” NCT03829488 ↗ “administration of mannitol or 3% saline for severe elevation of Intra Cranial Pressure” NCT04243655 ↗ “0.9% saline as distension medium as long as diathermy is not in use” NCT03166228 ↗ “followed by 0.9% saline intravenously at 1 ml/Kg/hr for 6 hours.” NCT00749827 ↗ “saline (0.9% sodium chloride)” NCT06076590 ↗ |
| Known as | Saline 0.9% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02875873 ↗ |
| Known as | Saline and Listerine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04802408 ↗ |
| Known as | Saline solution | “If there is contraindication for administration of bicarbonate the pattern of intravenous hydration is performed with saline solution: 3 ml / kg / h for 1 hour before the...” NCT02872155 ↗3“Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients.” PMID 20813485 ↗ Sep 2010 |
| Known as | Sodium Chloride 0.9% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02726620 ↗ |
| Known as | Sodium chloride injection | “Control group drug: Sodium chloride injection Manufacturer: Hua Run Shuang He Pharmaceutical Co., LTD.” NCT06076590 ↗ |
| Known as | Sodium chloride tablets | “Drug: Sodium chloride tablets” NCT01654328 ↗ |
| Known as | Table Salt | “The Active Rinse is a 25 ml of Hypertonic Saturated Saline solution made by mixing 10 grams of Sodium Chloride (Table Salt) in 25 ml of Tap water with some salt crystals deposited.” NCT04842721 ↗ |
| Modality | Other / unclassified | “crystalloid fluids (salt based, normal saline)” NCT00819416 ↗ |
| Route | Intravenous | “intravenous volume supplementation with either (A) sodium chloride 0.9%” PMID 22267245 ↗ Jan 2012 |